A Safety, Tolerability, and Efficacy Study of IBI314 in Ambulatory Patients With COVID-19
Public ClinicalTrials.gov record NCT05162365. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a dose-finding, inferentially seamless Phase 1/2 study evaluating the safety, tolerability and efficacy of IBI314 in Ambulatory Patients with COVID-19.
Study identification
- NCT ID
- NCT05162365
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 248 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 5, 2022
- Primary completion
- Jun 28, 2022
- Completion
- Nov 17, 2022
- Last update posted
- Dec 17, 2023
2022
United States locations
- U.S. sites
- 19
- U.S. states
- 5
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sobh | Anaheim | California | 92806 | — |
| Long Beach Clinical Trials, LLC | Long Beach | California | 90806 | — |
| Acclaim Clinical Research | San Diego | California | 92120 | — |
| Herco Research Center, Inc. | Coral Gables | Florida | 33134 | — |
| Midland Florida Clinical Research Center - Inf. Disease/Infectiology | DeLand | Florida | 32720 | — |
| Palm Springs Research Institute | Hialeah | Florida | 33012 | — |
| Sweet Hope Research Specialty, Inc | Hialeah | Florida | 33016 | — |
| Prestige Clinical Research Center Inc | Miami | Florida | 33133 | — |
| Cordova Research Institute, LLC | Miami | Florida | 33155 | — |
| Clinical Trials of Florida, LLC | Miami | Florida | 33186 | — |
| The Clinical Research Institute LLC | Miami Gardens | Florida | 33169 | — |
| Pembroke Clinical Trials | Pembroke Pines | Florida | 33028 | — |
| Luminous Clinical Research LLC - South Florida Urgent Care - Infectious Diseases | Pembroke Pines | Florida | 33029-2818 | — |
| Palm Beach Research Center | West Palm Beach | Florida | 33409 | — |
| Florida Pulmonary Research Institute, LLC | Winter Park | Florida | 32789 | — |
| Excel Clinical Research - Internal Medicine | Las Vegas | Nevada | 89109 | — |
| Temple University Health System - Temple Lung Center | Philadelphia | Pennsylvania | 19140-5103 | — |
| Zenos Clinical Research | Dallas | Texas | 75230 | — |
| Epic Clinical Research | Lewisville | Texas | 75057 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05162365, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 17, 2023 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05162365 live on ClinicalTrials.gov.